Medicaments, in measured doses or retail packs: South Korea exports and imports
HS 3004 · 의약품[혼합한 것인지에 상관없으며 치료용이나 예방용의 것으로서 일정한 투여량으로 한 것(피부 투여의 형식을 취한 것을 포함한다)과 소매용 모양이나 포장을 한 것으로 한정하며, 제3002호ㆍ제3005호ㆍ제3006호의 물품은 제외한다] · latest month: October 2026
In October 2026, South Korea exported $79.9 million of medicaments, in measured doses or retail packs (HS 3004), down 2.7% from September 2026 and up 29.9% from October 2025.
Over the 12 months to October 2026, exports of medicaments, in measured doses or retail packs (HS 3004) totalled $955.3 million, up 6.4% from the 12 months before ($898.2 million).
The largest destination over the 12 months to October 2026 was Vietnam ($128.4 million, 13.4% of the total), followed by Japan and China.
That was 9.3% of South Korea's exports under HS chapter 30 (pharmaceutical products) over the same 12 months.
Imports in October 2026 were $619.9 million (up 34.7% from October 2025), leaving a deficit of $540.1 million for the month.
Official description of HS 3004: Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale.
Last 24 months
Subheadings under HS 3004
| Code | Product | Exports, 12 months | Share | vs 12 months before | October 2026 |
|---|---|---|---|---|---|
| 3004.10 | Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives | $10.6M | 1.1% | -9.7% | $1.4M |
| 3004.10.1000 | Containing penicillins or derivatives thereof, with a penicillanic acid structure | $10.5M | 99.3% | -4.9% | $1.4M |
| 3004.10.2000 | Containing streptomycins or their derivatives | $75K | 0.7% | -88.8% | $728 |
| 3004.20 | Other, containing antibiotics | $56.4M | 5.9% | -9.3% | $4.7M |
| 3004.20.1000 | Anti-tuberculosis preparations, anthelmintic preparations and anti-cancer preparations | $6.7M | 11.8% | -27.8% | $744K |
| 3004.20.9100 | Preparations containing chloramphenicol | $3.8M | 6.8% | -2.8% | $270K |
| 3004.20.9300 | Preparations containing oxy-tetracycline | $588K | 1.0% | -17.3% | $12K |
| 3004.20.9900 | Other | $45.3M | 80.4% | -6.1% | $3.6M |
| 3004.31 | Containing insulin | $289 | 0.0% | – | $0 |
| 3004.32 | Containing corticosteroid hormones, their derivatives or structural analogues | $7.1M | 0.7% | +14.0% | $146K |
| 3004.39 | Other | $115.6M | 12.1% | +31.8% | $7.7M |
| 3004.39.1010 | Preparations containing pituitary (anterior) hormones | $76.4M | 66.1% | +29.5% | $4.3M |
| 3004.39.1020 | Preparations containing pituitary (posterior) hormones | $161K | 0.1% | +20.5% | $0 |
| 3004.39.3000 | Preparations containing thyroid and parathyroid hormones | $28K | 0.0% | -7.4% | $0 |
| 3004.39.5000 | Preparations containing adrenal medulla hormones | $49 | 0.0% | – | $0 |
| 3004.39.6000 | Preparations containing male sex hormones | $1.6M | 1.4% | +89.4% | $395K |
| 3004.39.7000 | Preparations containing estrogens and gestagens, progestins | $145K | 0.1% | +64.3% | $28K |
| 3004.39.9000 | Other | $37.3M | 32.3% | +34.8% | $2.9M |
| 3004.41 | Containing ephedrine or its salts | $2,331 | 0.0% | – | $0 |
| 3004.42 | Containing pseudoephedrine (INN) or its salts | $678K | 0.1% | +52.0% | $145K |
| 3004.49 | Other | $3.2M | 0.3% | -0.5% | $570K |
| 3004.49.1000 | Anti-cancer preparations | $2.4M | 75.0% | -14.1% | $386K |
| 3004.49.2020 | Preparations containing alkaloids of rye ergot | $0 | 0.0% | – | $0 |
| 3004.49.2030 | Preparations containing nicotine | $0 | 0.0% | – | $0 |
| 3004.49.3000 | Preparations containing atropine and homatropine | $0 | 0.0% | – | $0 |
| 3004.49.9000 | Other | $796K | 25.0% | +89.9% | $184K |
| 3004.50 | Other, containing vitamins or other products of heading 29.36 | $26.3M | 2.8% | -2.6% | $1.8M |
| 3004.50.1000 | Preparations containing vitamin A | $63 | 0.0% | – | $0 |
| 3004.50.2010 | Preparations containing vitamin B1 | $12K | 0.0% | -80.6% | $285 |
| 3004.50.2090 | Other | $294K | 1.1% | +37.5% | $8,925 |
| 3004.50.3000 | Preparations containing vitamin C | $1.5M | 5.9% | +24.4% | $226K |
| 3004.50.4000 | Preparations containing vitamin D | $1.1M | 4.1% | +5.0% | $42K |
| 3004.50.9000 | Other | $23.4M | 88.9% | -4.5% | $1.5M |
| 3004.60 | Other, containing antimalarial active principles described in Subheading Note 2 to this Chapter | $11.2M | 1.2% | +32.4% | $40 |
| 3004.90 | Other | $724.3M | 75.8% | +4.8% | $63.5M |
| 3004.90.1000 | Anti-tuberculosis preparations, anthelmintic preparations and anti-cancer preparations | $26.8M | 3.7% | +35.1% | $2.7M |
| 3004.90.9100 | Preparations containing aspirin | $188K | 0.0% | -37.8% | $0 |
| 3004.90.9200 | Preparations containing antihistamines | $1.8M | 0.2% | +13.8% | $97K |
| 3004.90.9900 | Other | $695.5M | 96.0% | +3.9% | $60.7M |
Six-digit codes are international; the indented ten-digit codes are South Korea's own subdivision. These rows are world totals; "Share" is the share of the row above.
Top destinations
Export value over the 12 months to October 2026. 154 countries received this product from South Korea in the last 24 months; the table shows the largest 20.
| Rank | Country | Exports, 12 months | Share | vs 12 months before | Rank before | October 2026 |
|---|---|---|---|---|---|---|
| 1 | Vietnam | $128.4M | 13.4% | +12.7% | 2 | $11.7M |
| 2 | Japan | $128.0M | 13.4% | -1.9% | 1 | $13.1M |
| 3 | China | $71.5M | 7.5% | +8.5% | 3 | $6.2M |
| 4 | Thailand | $70.5M | 7.4% | +7.6% | 4 | $6.7M |
| 5 | Philippines | $52.4M | 5.5% | +10.1% | 5 | $4.7M |
| 6 | Brazil | $42.6M | 4.5% | +35.2% | 7 | $3.4M |
| 7 | Mexico | $41.4M | 4.3% | +35.0% | 8 | $2.3M |
| 8 | Cambodia | $27.9M | 2.9% | +29.8% | 10 | $1.6M |
| 9 | United States | $27.5M | 2.9% | -22.6% | 6 | $1.6M |
| 10 | Taiwan | $23.3M | 2.4% | +20.8% | 12 | $3.4M |
| 11 | Mongolia | $21.3M | 2.2% | +2.8% | 11 | $1.9M |
| 12 | Hong Kong | $20.3M | 2.1% | -12.8% | 9 | $1.6M |
| 13 | Germany | $18.3M | 1.9% | -2.7% | 13 | $2.6M |
| 14 | Indonesia | $16.9M | 1.8% | +10.9% | 16 | $2.1M |
| 15 | United Arab Emirates | $16.1M | 1.7% | -8.3% | 14 | $638K |
| 16 | Malaysia | $15.3M | 1.6% | +6.2% | 17 | $988K |
| 17 | Pakistan | $14.6M | 1.5% | +14.2% | 18 | $1.4M |
| 18 | France | $13.1M | 1.4% | +3.4% | 19 | $1.4M |
| 19 | Belgium | $10.2M | 1.1% | -33.9% | 15 | $576K |
| 20 | Myanmar | $8.8M | 0.9% | -19.9% | 20 | $735K |
Countries are linked when exports of this product to them reached $5,000,000 over 24 months.
Monthly figures
| Month | Exports | vs year earlier | Export weight | Export $/kg | Imports | Import weight |
|---|---|---|---|---|---|---|
| October 2026 | $79.9M | +29.9% | 1,630 t | $49.02 | $619.9M | 6,378 t |
| September 2026 | $82.1M | -12.8% | 1,605 t | $51.18 | $513.5M | 6,662 t |
| August 2026 | $68.2M | +8.9% | 1,335 t | $51.11 | $590.0M | 5,593 t |
| July 2026 | $89.1M | +19.7% | 1,717 t | $51.93 | $548.3M | 7,115 t |
| June 2026 | $90.1M | +11.2% | 1,809 t | $49.78 | $581.1M | 6,037 t |
| May 2026 | $75.9M | -0.9% | 1,344 t | $56.50 | $579.1M | 5,599 t |
| April 2026 | $84.9M | +12.3% | 1,816 t | $46.75 | $630.8M | 6,607 t |
| March 2026 | $84.1M | +1.1% | 1,856 t | $45.31 | $538.1M | 5,887 t |
| February 2026 | $63.4M | +3.3% | 1,209 t | $52.49 | $432.2M | 5,557 t |
| January 2026 | $64.0M | +32.3% | 1,097 t | $58.32 | $413.4M | 5,886 t |
| December 2025 | $92.3M | -1.0% | 2,224 t | $41.49 | $409.8M | 6,752 t |
| November 2025 | $81.2M | -5.4% | 1,976 t | $41.11 | $434.2M | 5,278 t |
| October 2025 | $61.5M | -18.2% | 1,262 t | $48.75 | $460.2M | 6,325 t |
| September 2025 | $94.2M | +41.7% | 2,104 t | $44.76 | $504.6M | 6,022 t |
| August 2025 | $62.7M | +5.7% | 1,381 t | $45.39 | $514.6M | 4,883 t |
| July 2025 | $74.5M | -4.3% | 1,886 t | $39.49 | $460.9M | 5,747 t |
| June 2025 | $81.0M | +13.5% | 1,711 t | $47.35 | $427.4M | 6,394 t |
| May 2025 | $76.6M | +6.5% | 1,353 t | $56.64 | $362.7M | 5,808 t |
| April 2025 | $75.6M | +5.0% | 1,623 t | $46.58 | $426.4M | 6,462 t |
| March 2025 | $83.2M | +13.5% | 1,663 t | $50.02 | $384.9M | 4,824 t |
| February 2025 | $61.4M | +1.4% | 1,485 t | $41.36 | $375.9M | 5,946 t |
| January 2025 | $48.4M | -23.5% | 883 t | $54.77 | $330.0M | 5,980 t |
| December 2024 | $93.2M | +21.2% | 2,408 t | $38.72 | $358.1M | 4,783 t |
| November 2024 | $85.9M | +9.8% | 2,433 t | $35.30 | $368.2M | 5,555 t |
Exports FOB, imports CIF, US dollars. Weight is net weight. "vs year earlier" compares export value with the same month one year before and is left blank when that month was under $10,000. Source: Korea Customs Service, via data.go.kr.